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One of the main cause of ineffective cell therapy in repairing the damaged heart is
the poor yield of grafted cells. To overcome this drawback, rats with 4-week-old
myocardial infarction (MI) were injected in the border zone with human adipose-
derived stem cells (ADSCs) conveyed by poly(lactic-co-glycolic acid) microcarriers
(PAMs) releasing hepatocyte growth factor (HGF) and insulin-like growth factor-1
(IGF-1) (GFsPAMs). According to treatments, animals were subdivided into different
groups: MI_ADSC, MI_ADSC/PAM, MI_GFsPAM, MI_ADSC/GFsPAM, and untreated
MI_V. Two weeks after injection, a 31% increase in ADSC engraftment was observed
in MI_ADSC/PAM compared with MI_ADSC (p < 0.05). A further ADSC retention was
obtained in MI_ADSC/GFsPAM with respect to MI_ADSC (106%, p < 0.05) and
MI_ADSC/PAM (57%, p < 0.05). A 130% higher density of blood vessels of medium
size was present in MI_ADSC/GFsPAM compared with MI_ADSC (p < 0.01).
MI_ADSC/GFsPAM also improved, albeit slightly, left ventricular remodeling and
hemodynamics with respect to the other groups. Notably, ADSCs and/or PAMs, with
or without HGF/IGF-1, trended to induce arrhythmias in electrically driven,
Langendorff-perfused, hearts of all groups. Thus, PAMs releasing HGF/IGF-1
markedly increase ADSC engraftment 2 weeks after injection and stimulate healing
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